[文献资料]参 考 文 献

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab .Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either C ......